FDA Approved: ERZOFRI EXTENDED-RELEASE — Supplemental Application (Shandong Luye Pharmaceutical Co., Ltd.)

View source ↗

Summary

FDA approved a supplemental application for ERZOFRI EXTENDED-RELEASE (paliperidone palmitate) from Shandong Luye Pharmaceutical Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ERZOFRI EXTENDED-RELEASE (PALIPERIDONE PALMITATE)

Snippet

SUPPL AP for ERZOFRI EXTENDED-RELEASE (PALIPERIDONE PALMITATE)